BioVie Inc.
FORMULATIONS OF TERLIPRESSIN

Last updated:

Abstract:

The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.

Status:
Application
Type:

Utility

Filling date:

22 May 2020

Issue date:

28 Jul 2022